Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw
Author:
- 14 October 2011
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 22 (12) , 2951-2961
Abstract
In recent years, atypical femoral fractures and osteonecrosis of the jaw have emerged as potential complications of long-term bisphosphonate therapy; osteonecrosis of the jaw has also been reported in patients receiving high doses of denosumab. The pathophysiology of both conditions is poorly defined, and the underlying mechanisms are likely to differ. The initiation of atypical fractures in the lateral femoral shaft suggests that reduced tensile strength, possibly secondary to alterations in the material properties of bone resulting from low bone turnover, may be an important pathogenetic factor. Osteonecrosis of the jaw is characterised by infection, inflammation, bone resorption and bone necrosis, but the sequence in which these occur has not been established. However, the observation that bone resorption occurs in close proximity to microbial structures suggests that infection may be the most important trigger, often as a result of dental disease. Other possible pathogenetic factors include suppression of bone turnover, altered immune status and adverse effects of bisphosphonates on the oral mucosa.Keywords
This publication has 91 references indexed in Scilit:
- The Effect of Long-term Alendronate Treatment on Cortical Thickness of the Proximal FemurClinical Orthopaedics and Related Research, 2012
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyThe Lancet, 2011
- Femoral Insufficiency Fractures Associated with Prolonged Bisphosphonate TherapyClinical Orthopaedics and Related Research, 2010
- In vivo effects of zoledronic acid on oral mucosal epithelial cellsOral Diseases, 2010
- Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007Journal of Bone and Mineral Research, 2010
- Vitamin D and the Immune System: New Perspectives on an Old ThemeEndocrinology and Metabolism Clinics of North America, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinomaBone, 2009
- Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronateOsteoporosis International, 2008
- Case Report of Spontaneous, Nonspinal Fractures in a Multiple Myeloma Patient on Long-term Pamidronate and Zoledronic AcidHSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2008